ATE40994T1 - L-n-n-propylpipekolsaeure-2,6-xylidid und dessen herstellung. - Google Patents

L-n-n-propylpipekolsaeure-2,6-xylidid und dessen herstellung.

Info

Publication number
ATE40994T1
ATE40994T1 AT83902297T AT83902297T ATE40994T1 AT E40994 T1 ATE40994 T1 AT E40994T1 AT 83902297 T AT83902297 T AT 83902297T AT 83902297 T AT83902297 T AT 83902297T AT E40994 T1 ATE40994 T1 AT E40994T1
Authority
AT
Austria
Prior art keywords
xylidide
acid
propylpipecolic
yield
pipecolic
Prior art date
Application number
AT83902297T
Other languages
English (en)
Inventor
Af Ekenstam Bo Thuresson
Christer Bovin
Original Assignee
Astra Laekemedel Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Laekemedel Ab filed Critical Astra Laekemedel Ab
Application granted granted Critical
Publication of ATE40994T1 publication Critical patent/ATE40994T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT83902297T 1983-08-01 1983-08-01 L-n-n-propylpipekolsaeure-2,6-xylidid und dessen herstellung. ATE40994T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/NO1983/000029 WO1985000599A1 (en) 1983-08-01 1983-08-01 L-N-n-PROPYLPIPECOLIC ACID-2,6-XYLIDIDE AND METHOD FOR PREPARING THE SAME
EP83902297A EP0151110B1 (de) 1983-08-01 1983-08-01 L-n-n-propylpipekolsäure-2,6-xylidid und dessen herstellung

Publications (1)

Publication Number Publication Date
ATE40994T1 true ATE40994T1 (de) 1989-03-15

Family

ID=19907251

Family Applications (1)

Application Number Title Priority Date Filing Date
AT83902297T ATE40994T1 (de) 1983-08-01 1983-08-01 L-n-n-propylpipekolsaeure-2,6-xylidid und dessen herstellung.

Country Status (12)

Country Link
EP (1) EP0151110B1 (de)
JP (1) JPS60502054A (de)
AT (1) ATE40994T1 (de)
AU (1) AU560367B2 (de)
CY (1) CY1623A (de)
DE (1) DE3379266D1 (de)
DK (1) DK153546C (de)
FI (1) FI80020C (de)
HK (1) HK98391A (de)
MY (1) MY101904A (de)
SG (1) SG87991G (de)
WO (1) WO1985000599A1 (de)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE451840B (sv) * 1986-01-03 1987-11-02 Astra Laekemedel Ab Optiskt rent monohydrat av s-(-)-1-propyl-2',6'-pipekoloxylididhydroklorid, sett att framstella denna och farmaceutiska beredningar for lokalbedovning
PT86249B (pt) * 1987-02-06 1991-02-08 Fisons Corp Processo de preparacao de derivados de azaciclocarboxamida
US5047541A (en) * 1987-02-06 1991-09-10 Fisons Corporation 2-azacyclocarboxamide derivatives
SE9000288D0 (sv) * 1990-01-26 1990-01-26 Astra Ab New use
FR2702220B1 (fr) * 1993-03-03 1995-05-12 Synthelabo Dédoublement enzymatique de dérivés de 4-alkyl-2-pipéridine-carboxylate et utilisation des composés obtenus, comme intermédiaires de synthèse.
SE9302218D0 (sv) * 1993-06-28 1993-06-28 Ab Astra New use
ES2082703B1 (es) * 1993-11-04 1996-12-16 Inst Investigacion Desarrollo Nuevos derivados de ciclopropilo, procedimientos para su preparacion y aplicaciones.
US5777124A (en) * 1994-10-25 1998-07-07 Chiroscience Limited Process for preparing levobupivacaine and analogues thereof
GB9504876D0 (en) * 1995-03-10 1995-04-26 Chiroscience Ltd Compounds and process
SE9501808D0 (sv) * 1995-05-16 1995-05-16 Astra Ab New process
GB9704351D0 (en) * 1997-03-03 1997-04-23 Chiroscience Ltd Levobupivacaine and its use
US7799337B2 (en) 1997-07-21 2010-09-21 Levin Bruce H Method for directed intranasal administration of a composition
SE9800139D0 (sv) 1998-01-21 1998-01-21 Astra Ab New use
US7247729B2 (en) 2001-09-10 2007-07-24 Mercian Corporation Method for producing pipecolamide derivative
US7683175B2 (en) 2005-06-06 2010-03-23 Navinta, Llc Process of making optically pure L-pipecolic acid and process of making anesthetics and intermediates therefrom
ITMI20051144A1 (it) * 2005-06-17 2006-12-18 Molteni & C Dei Fratellei Alit "procedimento per la preparazione d'una soluzione iniettabile di (2s)-n-(2;6-dimetil-fenil)-1-propil-2-piperidincarbossiamide"
JP2009535327A (ja) * 2006-04-25 2009-10-01 ディシュマン・ファーマシューティカルズ・アンド・ケミカルズ・リミテッド ロピバカイン塩酸塩無水物およびその調製
AU2007322033B2 (en) 2006-11-20 2013-07-11 President And Fellows Of Harvard College Methods, compositions, and kits for treating pain and pruritis
KR100844336B1 (ko) * 2007-01-16 2008-07-07 하나제약 주식회사 레보부피바카인 및 이의 염산염의 신규한 제조방법
US8227114B2 (en) 2007-07-05 2012-07-24 Samsung Sdi Co., Ltd. Preparing method of negative active material for non-aqueous electrolyte secondary battery and negative active material prepared thereby
WO2009044404A1 (en) * 2007-10-01 2009-04-09 Ramniwas Goel Process for the preparation of (s)-ropivacaine hydrochloride monohydrate
WO2009089841A1 (en) * 2008-01-15 2009-07-23 Pharmathen S.A. Process for the preparation of (s)-1-alkyl-2',6'-pipecoloxylidide compound
US8473062B2 (en) 2008-05-01 2013-06-25 Autonomic Technologies, Inc. Method and device for the treatment of headache
US8412336B2 (en) 2008-12-29 2013-04-02 Autonomic Technologies, Inc. Integrated delivery and visualization tool for a neuromodulation system
US9320908B2 (en) 2009-01-15 2016-04-26 Autonomic Technologies, Inc. Approval per use implanted neurostimulator
US8494641B2 (en) 2009-04-22 2013-07-23 Autonomic Technologies, Inc. Implantable neurostimulator with integral hermetic electronic enclosure, circuit substrate, monolithic feed-through, lead assembly and anchoring mechanism
JP6205133B2 (ja) 2009-07-10 2017-09-27 プレジデント アンド フェローズ オブ ハーバード カレッジ 抗炎症剤としての恒久的に荷電したナトリウムおよびカルシウムチャンネルブロッカー
RU2504538C2 (ru) * 2012-04-17 2014-01-20 Государственное бюджетное образовательное учреждение высшего профессионального образования "Пермская государственная фармацевтическая академия" Министерства здравоохранения и социального развития Российской Федерации (ГБОУ ВПО ПГФА Минздравсоцразвития России) 2,6-диметиланилид n-циклогексилпирролидин-2-карбоновой кислоты гидрохлорид, проявляющий активность при поверхностной, инфильтрационной и проводниковой анестезии
US9108942B1 (en) 2014-11-05 2015-08-18 Mahesh Kandula Compositions and methods for the treatment of moderate to severe pain
CN103073484B (zh) * 2013-01-28 2014-10-22 山东诚创医药技术开发有限公司 一种甲哌卡因及其光学对映体的制备方法
US9333187B1 (en) 2013-05-15 2016-05-10 Cellix Bio Private Limited Compositions and methods for the treatment of inflammatory bowel disease
SG11201509782TA (en) 2013-06-04 2015-12-30 Cellix Bio Private Ltd Compositions and methods for the treatment of diabetes and pre-diabetes
CN103304471B (zh) * 2013-07-12 2015-02-04 四川省惠达药业有限公司 一种甲磺酸罗哌卡因化合物、其制备方法及其药物组合物
US9096537B1 (en) 2014-12-31 2015-08-04 Mahesh Kandula Compositions and methods for the treatment of mucositis
NZ736131A (en) 2014-09-26 2019-04-26 Cellix Bio Private Ltd Compositions and methods for the treatment of epilepsy and neurological disorders
ES2799309T3 (es) 2014-09-29 2020-12-16 Cellix Bio Private Ltd Compuestos y composiciones para el tratamiento de esclerosis múltiple
US9173877B1 (en) * 2014-11-05 2015-11-03 Cellix Bio Private Limited Compositions and methods for the treatment of local pain
WO2016088132A1 (en) 2014-12-01 2016-06-09 Cellix Bio Private Limited Compositions and methods for the treatment of multiple sclerosis
SG11201705524SA (en) 2015-01-06 2017-08-30 Cellix Bio Private Ltd Compositions and methods for the treatment of inflammation and pain
KR20180069782A (ko) 2015-08-03 2018-06-25 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 하전 이온 채널 블록커 및 이용 방법
US10828287B2 (en) 2019-03-11 2020-11-10 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
AU2020235888A1 (en) 2019-03-11 2021-09-30 Nocion Therapeutics, Inc. Charged ION channel blockers and methods for use
US10780083B1 (en) 2019-03-11 2020-09-22 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
MX2021010869A (es) 2019-03-11 2022-01-19 Nocion Therapeutics Inc Bloqueadores de canales iónicos sustituidos por éster y métodos para su uso.
US10934263B2 (en) 2019-03-11 2021-03-02 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
CN114828845A (zh) 2019-11-06 2022-07-29 诺西恩医疗公司 带电的离子通道阻滞剂及其使用方法
US10933055B1 (en) 2019-11-06 2021-03-02 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US12162851B2 (en) 2020-03-11 2024-12-10 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
CN119118953A (zh) 2020-03-11 2024-12-13 诺西恩医疗公司 带电的离子通道阻滞剂及其使用方法
CN112294809B (zh) * 2020-11-20 2022-03-29 四川大学华西医院 一种低毒性局部麻醉药及其制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE341404B (de) * 1967-05-18 1971-12-27 Sterling Drug Inc

Also Published As

Publication number Publication date
JPH0559903B2 (de) 1993-09-01
DK135685A (da) 1985-03-26
AU1779683A (en) 1985-03-04
DK153546B (da) 1988-07-25
AU560367B2 (en) 1987-04-02
EP0151110B1 (de) 1989-03-01
DK153546C (da) 1988-12-05
SG87991G (en) 1991-11-22
CY1623A (en) 1992-07-10
FI851266L (fi) 1985-03-29
FI80020C (fi) 1990-04-10
FI851266A0 (fi) 1985-03-29
HK98391A (en) 1991-12-13
DK135685D0 (da) 1985-03-26
DE3379266D1 (en) 1989-04-06
EP0151110A1 (de) 1985-08-14
WO1985000599A1 (en) 1985-02-14
JPS60502054A (ja) 1985-11-28
FI80020B (fi) 1989-12-29
MY101904A (en) 1992-02-15

Similar Documents

Publication Publication Date Title
ATE40994T1 (de) L-n-n-propylpipekolsaeure-2,6-xylidid und dessen herstellung.
ES2044836T3 (es) Derivado de la piperidina, su utilizacion y compuesto farmaceutico que lo contiene.
DK165003C (da) Chlorsulfat
ES2115096T3 (es) Derivados tetrazolicos de acidos biliares, procedimiento para su preparacion y utilizacion de estos compuestos como medicamentos.
ATE46501T1 (de) Abkoemmlinge der guanidinomethylbenzoesaeure.
BR8500851A (pt) Processo para produzir um derivado de benzoilureia e processo para produzir uma composicao inseticida e/ou ovicida
DK196688A (da) Bicykliske forbindelser og fremgangsmaade til fremstilling deraf
FI870090A0 (fi) Laongkedjade alkylresorcinolfosfiter.
FR2358141A1 (fr) Nouveaux anesthesiques locaux
ATE60779T1 (de) N-glykolylneuraminsaeurederivat.
ES471356A1 (es) Procedimiento de obtencion de r,s-2,3,5,6-tetrahidro-6-fenil-imidazo (2,1-b)-tiazole (tetramisole)
ATE45576T1 (de) Dibenzopyranderivate.
FR2587334B1 (fr) Procede de preparation d'acides bromofluoro-acetiques
IT1250655B (it) Derivato dell'acido 4-clorofenossiacetico ad attivita' antiossidante eantiinvecchiamento.
ES8603707A1 (es) Procedimiento para la obtencion del acido 1,8-dietil-1,3,4,9-tetrahidropirano (3,4-b) indol-1-acetico
JPS53124277A (en) 1-substed-(1,2-diphenylpropyl)piperazines

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time